Fri 03'rd Aug 2018
Iovance Biotherapeutics, Inc. Stock Analysis
Technical stock analysis for Fri 03'rd Aug 2018
|Shorts||5.93% ( 2018-07-13 )|
Iovance Biotherapeutics, Inc. fell by -1.43% in the last day from $13.95 to $13.75 The price has fallen in 7 of the last 10 days and is down by -7.72% for this period. Volume has increased in the last day by 65 547 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 481 472 shares bought and sold for approximately $6.62 million.
Iovance Biotherapeutics, Inc. lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -12.58% during the next 3 months and, with 90% probability hold a price between $9.74 and $13.22 at the end of this period.
There are mixed signals in the stock today. A sales signal was issued from a pivot top point on Thursday August 02, 2018, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. Iovance Biotherapeutics, Inc. holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $13.76. On a fall, the stock will find some support from the long-term average at approximately $13.65. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal.
Relative Strength Index (RSI)
RSI14 is 49 and the stock is currently not being overbought or oversold
Support & Resistance
Iovance Biotherapeutics, Inc. finds support from accumulated volume at $13.60.
This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $0.53 (3.83%) between high and low. For the last week, the stock has had a daily average volatility of 6.21%.
Our recommended stoploss: $13.20 (-3.98%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from pivot top found 1 days ago.)
Very Low Low Medium High Very High
Iovance Biotherapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Hold/Accumulate.Click for Top 5 Hold/Accumulates